.ANALYSIS FEATURE.06 August 2024.
A large randomized controlled trial with cisgender females highlights the obstacles of faithfulness to an everyday dental preexposure prevention routine as well as shows that twice-yearly shot of lenacapavir may preserve helpful HIV avoidance degrees over 6 months.